# FDA Inspection 1174252 - Eurofins Amatsi Analytics - August 05, 2021

Source: https://www.keypedia.com/records/fda_inspections/eurofins-amatsi-analytics/c2c30371-9c6b-4491-84f9-1e1abc994c96
Source feed: FDA_Inspections

> FDA Inspection 1174252 for Eurofins Amatsi Analytics on August 05, 2021. Classification: Voluntary Action Indicated (VAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1174252
- Company Name: Eurofins Amatsi Analytics
- Inspection Date: 2021-08-05
- Classification: Voluntary Action Indicated (VAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1224183 - 2023-11-03](https://www.keypedia.com/records/fda_inspections/eurofins-amatsi-analytics/aed3d852-5c11-41b6-a617-8bef1b4eb2c9)
- [FDA Inspection 990192 - 2016-09-28](https://www.keypedia.com/records/fda_inspections/eurofins-amatsi-analytics/c3888bc8-654f-4da0-948b-86d7417466d3)
- [FDA Inspection 865532 - 2014-02-04](https://www.keypedia.com/records/fda_inspections/eurofins-amatsi-analytics/b6176a67-e8d6-48d1-888e-07208daeb0fd)
- [FDA Inspection 865532 - 2014-02-04](https://www.keypedia.com/records/fda_inspections/eurofins-amatsi-analytics/0f69c990-59ff-4653-9444-b854e608e828)
- [FDA Inspection 706532 - 2010-10-08](https://www.keypedia.com/records/fda_inspections/eurofins-amatsi-analytics/ca462167-b1c1-4c90-aa35-ff2f694a06f4)

Company: https://www.keypedia.com/companies/eurofins-amatsi-analytics/b634a442-c268-4779-920a-c50afd3e3af2

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c